P
Pixelgen
Spatial proteomics platform mapping the molecular architecture of individual cells
About Pixelgen
Pixelgen is a Stockholm, Sweden life-sciences company founded in 2020 by Simon Fredriksson, Alvaro Martinez Barrio, Fredrik Dahl and Filip Karlsson. Its Proxiome platform uses DNA-based Molecular Pixelation to map how proteins are organized, clustered and positioned on the surface of single cells, adding spatial architecture to conventional protein-abundance measurements. The company emerged from stealth in 2022 and closed an oversubscribed $15.5 million Series B in August 2026, led by Flat Capital with continued participation from Industrifonden and Navigare Ventures, to commercialize globally. CEO and co-founder Simon Fredriksson previously co-founded Olink and Genagon Therapeutics; other founding expertise includes computational science and product development at 10x Genomics, Halo Genomics and Vanadis.
Source: Dealroom company dataAt a glance
- Founded
- 2020
- Headquarters
- Stockholm, Sweden
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Navigare Ventures
Colibri Ventures
European Innovation Council
Series A1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pixelgen on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pixelgen on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.